MedPath

The effect of exercise on type 2 diabetes

Not Applicable
Conditions
Type II diabetes mellitus.
Registration Number
IRCT20190128042529N1
Lead Sponsor
Vice Chancellor of Research Ferdowsi University of Mashhad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Confirmation of Type 2 Diabetes (Fasting blood glucose greater than 126 mg/dL, Oral glucose tolerance test equal to or greater than 200 mg/dL, A1C level of 6.5 percent or higher)
BMI 28-35
Age between 40-50 years

Exclusion Criteria

use insulin
having  cardiovascular diseases, musculoskeletal disorders, liver disease, kidney disease, thyroid dysfunction
having regular physical activity in at least the last six months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: HOMA-IR method.;Glucagon-like peptide-1 (GLP-1). Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: ELISA method.;HbA1C. Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: Nyco Card device.;ALP. Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: spectrophotometry method.;Aspartate aminotransferase (SGOT or AST). Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: spectrophotometry method.;Alanine aminotransferase (SGPT or ALT). Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: spectrophotometry method.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath